Spaulding to hold lecture on pain management

Posted by Reeve Staff in Daily Dose on October 15, 2019 # News, Events

The Spaulding New England Regional Spinal Cord Injury Center is offering a lecture on October 17 in Charlestown, Massachusetts. The title of the lecture is entitled: Management of chronic central neuropathic pain following spinal cord injuries & disorders and will be hosted by Dr. Christine Sang, MD, MPH. Dr. Sang is the Director of Translational Pain Research Department of Anesthesiology at Brigham and Women’s Hospital. She previously served as Associate Medical Director of the Pain Research Clinic at the National Institutes of Health.

Beyond the impairments in strength and sensation that can occur after a spinal cord injury or disorder (SCI/D), damage to the spinal cord can involve some degree of neuropathic pain at the level of or below the injury. One usually hears such pain described as a burning feeling or a sharp, shooting feeling. However, neuropathic pain experience can differ from person to person. People who experience such chronic pain could find that their quality of life and their ability to fully participate in society diminishes. This lecture will review the different types of pain, with a focus on neuropathic pain and treatment options or approaches available.

At the end of this presentation, learners will be able to:

  • Classify the different types of pain following SCI/D
  • Summarize key challenges to analgesic treatments for central neuropathic pain following SCI/D
  • Recognize that complex set of pain mechanisms coexist following SCI/D, and that treatment likely need to be individualized

To register for the dinner and lecture or to join remotely via webcast, visit or contact Jenny Min at [email protected]

For more information please also download our Pain Management booklet or our video on the topic on our YouTube channel.

The National Paralysis Resource Center website is supported by the Administration for Community Living (ACL), U.S. Department of Health and Human Services (HHS) as part of a financial assistance award totaling $8,700,000 with 100 percent funding by ACL/HHS. The contents are those of the author(s) and do not necessarily represent the official views of, nor an endorsement, by ACL/HHS, or the U.S. Government.